GI Cancers

A Curated Room: The People Shaping Practice

Now in its third year, this invitation-only meeting convenes a deliberately small faculty: 24 leading gastrointestinal oncology KOLs alongside 24 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.

The science follows the disease, session by session: colorectal from early stage through metastatic biomarker-driven selection, pancreas and biliary, gastric and esophageal disease, HCC, neuroendocrine tumors, and anal and other rare GI sites. Every session pairs expert talks with a moderated panel, sustained, close-quarters engagement rather than a lecture hall.